全文获取类型
收费全文 | 252731篇 |
免费 | 61404篇 |
国内免费 | 12085篇 |
专业分类
耳鼻咽喉 | 3318篇 |
儿科学 | 6648篇 |
妇产科学 | 2068篇 |
基础医学 | 31676篇 |
口腔科学 | 8199篇 |
临床医学 | 34525篇 |
内科学 | 44366篇 |
皮肤病学 | 9489篇 |
神经病学 | 19953篇 |
特种医学 | 8763篇 |
外国民族医学 | 71篇 |
外科学 | 31500篇 |
综合类 | 39584篇 |
现状与发展 | 57篇 |
一般理论 | 34篇 |
预防医学 | 19907篇 |
眼科学 | 5377篇 |
药学 | 25084篇 |
217篇 | |
中国医学 | 15353篇 |
肿瘤学 | 20031篇 |
出版年
2024年 | 774篇 |
2023年 | 2816篇 |
2022年 | 7180篇 |
2021年 | 10360篇 |
2020年 | 12186篇 |
2019年 | 15758篇 |
2018年 | 15611篇 |
2017年 | 17095篇 |
2016年 | 17208篇 |
2015年 | 20286篇 |
2014年 | 22000篇 |
2013年 | 22964篇 |
2012年 | 19761篇 |
2011年 | 20763篇 |
2010年 | 21378篇 |
2009年 | 15697篇 |
2008年 | 13858篇 |
2007年 | 12095篇 |
2006年 | 11338篇 |
2005年 | 9491篇 |
2004年 | 6884篇 |
2003年 | 6509篇 |
2002年 | 5598篇 |
2001年 | 4470篇 |
2000年 | 3533篇 |
1999年 | 2416篇 |
1998年 | 1251篇 |
1997年 | 1157篇 |
1996年 | 926篇 |
1995年 | 838篇 |
1994年 | 640篇 |
1993年 | 411篇 |
1992年 | 473篇 |
1991年 | 364篇 |
1990年 | 337篇 |
1989年 | 266篇 |
1988年 | 227篇 |
1987年 | 222篇 |
1986年 | 175篇 |
1985年 | 135篇 |
1984年 | 89篇 |
1983年 | 72篇 |
1982年 | 50篇 |
1981年 | 58篇 |
1980年 | 33篇 |
1979年 | 56篇 |
1978年 | 33篇 |
1977年 | 40篇 |
1974年 | 37篇 |
1973年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
目的 探讨剂量组学在预测肺癌根治性放疗患者放射性肺炎发生中的应用潜能。方法 回顾性收集行根治性放疗的314例肺癌患者的临床资料、放疗剂量文件、定位及随访CT图像,根据临床资料及影像学随访资料对放射性肺炎进行分级,提取全肺的剂量组学特征,构建机器学习模型。应用1000次自助抽样法(bootstrap)的最小绝对值收敛和选择算子嵌套逻辑回归(LASSO‐LR)及1000次bootstrap的赤池信息量准则(AIC)向后法筛选与放射性肺炎相关的剂量组学特征,随机按照7∶3划分为训练集及验证集,应用逻辑回归建立预测模型,并应用ROC曲线及校正曲线评价模型的性能。结果 共提取120个剂量组学特征,经LASSO‐LR降维筛选得到12个特征进入“特征池”,再经过AIC向后法筛选,最终筛选出6个剂量组学特征进行模型构建,训练集AUC为0.77(95%CI为0.65~0.87),独立验证集AUC为0.72(95%CI为0.64~0.81)。结论 利用剂量组学建立的预测模型具有预测放射性肺炎发生的潜力,但仍需继续纳入多中心数据及前瞻性数据进一步挖掘剂量组学的应用潜能。 相似文献
83.
84.
Enrique Luengo Izaskun Buendia Cristina Fernndez‐Mendívil Paula Trigo‐Alonso Pilar Negredo Patrycja Michalska Borja Hernndez‐García Cristina Snchez‐Ramos Juan A. Bernal Tsuneya Ikezu Rafael Len Manuela G. Lpez 《Journal of pineal research》2019,67(1)
Alterations in autophagy are increasingly being recognized in the pathogenesis of proteinopathies like Alzheimer's disease (AD). This study was conducted to evaluate whether melatonin treatment could provide beneficial effects in an Alzheimer model related to tauopathy by improving the autophagic flux and, thereby, prevent cognitive decline. The injection of AAV‐hTauP301L viral vectors and treatment/injection with okadaic acid were used to achieve mouse and human ex vivo, and in vivo tau‐related models. Melatonin (10 μmol/L) impeded oxidative stress, tau hyperphosphorylation, and cell death by restoring autophagy flux in the ex vivo models. In the in vivo studies, intracerebroventricular injection of AAV‐hTauP301L increased oxidative stress, neuroinflammation, and tau hyperphosphorylation in the hippocampus 7 days after the injection, without inducing cognitive impairment; however, when animals were maintained for 28 days, cognitive decline was apparent. Interestingly, late melatonin treatment (10 mg/kg), starting once the alterations mentioned above were established (from day 7 to day 28), reduced oxidative stress, neuroinflammation, tau hyperphosphorylation, and caspase‐3 activation; these observations correlated with restoration of the autophagy flux and memory improvement. This study highlights the importance of autophagic dysregulation in tauopathy and how administration of pharmacological doses of melatonin, once tauopathy is initiated, can restore the autophagy flux, reduce proteinopathy, and prevent cognitive decline. We therefore propose exogenous melatonin supplementation or the development of melatonin derivatives to improve autophagy flux for the treatment of proteinopathies like AD. 相似文献
85.
86.
87.
88.
Very preterm children are at increased risk of reduced processing speed at 5 years of age,predicted by typical complications of prematurity and prenatal smoking 下载免费PDF全文
89.
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep 下载免费PDF全文
Flavio Torres Alejandro González‐Candia Camilo Montt Germán Ebensperger Magdalena Chubretovic María Serón‐Ferré Roberto V. Reyes Aníbal J. Llanos Emilio A. Herrera 《Journal of pineal research》2015,58(3):362-373
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN. 相似文献
90.